Avadel Pharmaceuticals Plc (AVDL)
21.32
-0.02
(-0.09%)
USD |
NASDAQ |
Dec 08, 16:00
21.30
-0.02
(-0.07%)
Pre-Market: 20:00
Avadel Pharmaceuticals Enterprise Value: 2.028B for Dec. 8, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Alkermes Plc | 3.817B |
| Jazz Pharmaceuticals Plc | 13.65B |
| Medtronic Plc | 150.79B |
| STERIS Plc (Ireland) | 27.41B |
| Amarin Corp. Plc | 30.49M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.02M |
| Revenue (Quarterly) | 77.47M |
| Total Expenses (Quarterly) | 77.45M |
| EPS Diluted (Quarterly) | 0.0002 |
| Profit Margin (Quarterly) | 0.03% |
| Earnings Yield | -0.03% |
| Operating Earnings Yield | 0.22% |
| Normalized Earnings Yield | -0.0258 |